- Telehealth Visits
- Insurance plan information
Anthony Wong, PharmD
He | Him | His- Telehealth Visits
- Insurance plan information
Anticoagulation Parnassus
Anthony Wong, PharmD
He | Him | HisAnticoagulation Parnassus
- Telehealth Visits
- Insurance plan information
On this page
About me
Anthony Wong is a pharmacist with expertise in managing the needs of critically ill patients. In addition to overseeing medications for patients in the intensive care unit, he cares for patients on blood-thinning medications.
Wong earned his doctor of pharmacy degree at UCSF. He completed residencies in acute care pharmacy and critical care pharmacy at UC San Diego Health.
Education & training
Board certification
- Critical Care Pharmacy, Board of Pharmacy Specialties
Degree
- PHARMD, UCSF School of Pharmacy
Locations
Component Name: Provider Research Listing component built but no clinical trials or publications to display
Clinical Trials query: q=health_gateway_id_ss%3A%28%225130%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%225130%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.